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ABSTRACT
Vaccination of healthcare workers (HCWs) against measles is strongly recommended in Europe. In this
study, we examined the impact of measles on Italian HCWs by systematically and quantitatively
analyzing measles cases involving HCWs over time and by identifying the epidemiological characteristics
of the respective measles outbreaks. We retrieved data on measles cases from the Italian national
integrated measles and rubella surveillance system from January 2013 to May 2019. Additionally, we
performed a systematic review of the literature and an analysis of the measles and rubella aggregate
outbreaks reporting forms from 2014 to 2018. Our review suggests that preventing measles infection
among HCWs in disease outbreaks may be crucial for the elimination of measles in Italy. National policies
aiming to increase HCW immunization rates are fundamental to the protection of HCWs and patients,
will limit the economic impact of outbreaks on the institutions affected and will help achieve the
elimination goal.
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Introduction
In recent years, a dramatic drop in measles vaccination cover-
age, which is likely responsible for multiple epidemic peaks,
has been registered in Europe.1,2 In 2017, Italy suffered one of
the highest measles infection rates3-5 and its Parliament
approved an extraordinary ordinance (Italian Decree Law
n. 73/2017) that extended the number of compulsory vaccina-
tions for school admission and included vaccination against
measles.6 After the introduction of this law, official data
indicate an increase in childhood immunization coverage.7,8
Despite this encouraging progress, measles has continued to
spread across the country. According to the Italian National
Institute of Health (NIH), 1334 measles cases were registered
in the first six months of 2019, more than 80% of which
occurred in people aged between 15 and 64 years,9 suggesting
a significant vaccination gap among young people and adults
in Italy.
In this context, growing attention has been paid to health-
care workers (HCWs): compared to the general population,
HCWs are estimated to be at greater risk of acquiring vaccine
preventable diseases such as measles, exposing both their
colleagues and patients to contagion.10,11 Measles can easily
spread across nosocomial settings where a large number of
contacts is possible:11,12 measles infections may be associated
with a high risk of poor outcomes for hospitalized patients12,13
and can cause a huge economic impact on the healthcare
centers affected.14,15 Currently, although HCW vaccination
against measles is strongly recommended in Italy,16 in 2018
two Italian Regions, Emilia-Romagna and Puglia, were forced
to introduce a regulatory restriction when hiring HCWs to
check their immune status; where susceptible workers refuse
vaccination, they are reallocated away from high-risk settings
(i.e. Oncology, Hematology) to other wards.17,18
A few researchers have investigated the impact of
measles on HCWs10,19,20 or have assessed their immune
status,21-24 often yielding disturbing results. Thus, further
research is needed to understand the extent of vaccine
noncompliance among HCWs and to develop effective
measures to combat this behavior. To the best of our
knowledge, this is the first systematic analysis of the evi-
dence on measles cases and HCWs. In particular, this study
has two purposes: first, we aimed to investigate measles
cases among HCWs and to quantify the issue over
time; second, we wished to identify the epidemiological
characteristics of the measles outbreaks involving HCWs
to make available further information relevant to the public
health debate on vaccination policies.
Methods
To provide a comprehensive picture of the phenomenon,
multiple data sources were investigated. Thus, to analyze
measles cases in HCWs, we retrieved data from the national
integrated measles and rubella surveillance system, whereas to
investigate the key features of measles outbreaks involving
HCWs, we performed a systematic review of the literature
and an analysis of the measles and rubella aggregate outbreaks
reporting forms.
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Analysis of measles cases among HCWs
Since 1st January 2013, measles and rubella surveillance has
been integrated in a unique surveillance system. All 19 Regions
and the two Autonomous Provinces (APs) of Italy, hereafter
collectively referred to as “Regions”, participate in the scheme
by reporting through an online platform. In this study, we
analyzed the reported measles cases involving HCWs from
database inception to 15th May 2019. For each case, additional
data were retrieved: date and Region, HCW characteristics
(gender, age, vaccination status), virus genotype, setting (hos-
pital: emergency department or ward; community: family,
school, other workplace, nomadic camp), case classification
(confirmed, probable or possible) and type (sporadic: when it
was not part of an outbreak; outbreak-associated: when a link
with other cases was established). Case classification was based
on the standard European Union case definition.25
Analysis of measles outbreaks involving HCWs
Systematic review of the literature
This review employs the methods outlined in the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement.26-28
Selection criteria, search methods and study selection
We included any report that respected the following criteria:
(i) describes one or more measles outbreaks; (ii) the outbreak/
s occurred in Italy; (iii) at least one HCW was infected.
A HCW was defined as a person engaged in actions whose
primary intent is to improve the health of members of the
public, and included students, nurses, physicians and other
paramedical professional figures.29 A measles outbreak was
defined as two or more linked cases, either epidemiologically
or by genotype. We excluded articles that described hospital
measles outbreaks where none of the aforementioned person-
nel was infected. Reports in English or Italian were considered
eligible. No time restriction was applied.
The review was performed by searching the bibliographic
databases Pubmed, Scopus and ISI Web of Science. The
search terms were grouped in the following string: (Epidem*
OR Outbreak) AND measles AND Ital* AND (nosocom* OR
healthcare OR health-care OR health care OR hospital*). The
string was adapted to fit the search criteria of each database.
The search was supplemented by exploring the web sites of
the Regions for other reports describing measles outbreaks
involving HCWs in Italy and by scanning the reference lists of
all the relevant articles we retrieved.
Duplicate articles were removed, and the title and abstract of
all retrieved records were screened. Studies that did not meet the
inclusion criteria were excluded. Full texts of potentially relevant
articles were examined by two researchers and reasons for exclu-
sion were recorded. When outbreak reports were updated by
other reports, only the most recent was analyzed. Disagreements
were resolved by consensus or by a third reviewer.
Data collection and quality assessment
Articles were divided into two categories according to the
description of the outbreaks. When the record described
more than one outbreak simultaneously (i.e. multiple out-
breaks), the following information was retrieved: first
author and year of publication; start date and end date;
geographic area where the outbreaks took place; number
of infected HCWs out of the total number of confirmed
cases; virus genotype. For articles investigating outbreaks
separately (i.e. single outbreaks), the following data were
collected for each of them: first author and year of publica-
tion; start date and end date of the measles outbreak; Region
or Province involved; description of the index case; setting;
number of infected HCWs out of the total number of cases
(i.e. outbreak size); virus genotype. The outbreak setting was
defined as “hospital” if it originated and/or spread within
the healthcare environment; “community” if it originated
and/or spread elsewhere and did not reach the healthcare
environment; “hospital-community” if both settings were
involved.
The quality assessment was performed using the ORION
statement, a 22-item checklist for Outbreak Reports and
Intervention Studies of Nosocomial infection.30 Two reviewers
independently assessed report quality and disagreements were
resolved by consensus or by a third reviewer.
Measles and rubella aggregate outbreaks reporting forms
The measles and rubella aggregate outbreak reporting forms
are part of the Annual Status Update, a national report which
is submitted annually to the World Health Organization
(WHO) Regional Office for Europe by the Italian National
Verification Committee for Measles and Rubella Elimination.
Each form relates to one outbreak and is made up of two
parts: 1) data on outbreak identification, case detail and
laboratory detail; 2) two boxes for the description of the
main epidemiological findings of the outbreak and the control
measures, respectively.31 The forms for the five-year period
2014–2018 were retrieved and all the outbreaks involving at
least one HCW were analyzed. The same criteria used to
collect information on the single measles outbreaks retrieved
from the systematic review were applied to each outbreak
reporting form. For the outbreak size, it was deemed small if
it involved from two to five people; medium if it involved
from six to ten people; large if it involved more than ten
people.
Results
Analysis of measles cases among HCWs
Among the measles cases which occurred in working-age
people, there was considerable year-to-year variation in both
the total number of cases and the proportion reported in
HCWs: the national surveillance system registered 119 cases
in HCWs out of a total of 1472 (8.1%) in 2013, 83/1066 (7.8%)
in 2014, 2/148 (1.4%) in 2015, 66/459 (14.4%) in 2016, 334/
3796 (8.8%) in 2017 and 126/1871 (6.7%) in 2018. Table 1
shows the characteristics of the measles cases notified as
involving HCWs.
More than 65% of the total number of HCW measles cases
occurred in six Regions (Lazio, Lombardia, Toscana, Sicilia,
Emilia-Romagna and Piemonte), that are among the nine
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most heavily populated Italian Regions and are also the six
Regions where approximately 70% of the total number of
measles cases occurred between 2013 and 2018 (data not
shown). Only Molise and Valle d’Aosta reported no involve-
ment of HCWs over the study period.
There were approximately twice as many female as male
HCWs with measles across all years, with the exception of
2015 and 2018 when the two groups were similarly repre-
sented. Almost 70% of the infected HCWs were 18–39 years
old and, of the 676 HCWs whose information on vaccination
status was available, 90% were unvaccinated, a small
percentage (7.1%) had received only one dose of vaccine,
and smaller proportions had two doses or unknown doses of
vaccine.
Virus genotype was reported in only 203 HCW cases, with B3
being the variant most frequently identified (66.0%). B3 started
to circulate in 2014 and it was consistently found in more than
65% of HCW cases in subsequent years. In contrast, D8 was
isolated in 64 HCWs (31.5% of the total genotyped cases); it
represented the most frequent variant in 2013 and decreased in
following years. The remaining genotypes were isolated in only
one or two cases each throughout the study period.
Table 1. Characteristics of measles cases notified in Italy as involving healthcare workers (HCWs) in the national integrated measles and rubella surveillance system
from 2013 to 2018.
Total 2013–2018 2013 2014 2015 2016 2017 2018
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Region 730 (100) 119 (100) 83 (100) 2 (100) 66 (100) 334 (100) 126 (100)
Piemonte 57 (7.8) 16 (13.4) 5 (6.0) 0 (0.0) 7 (10.6) 29 (8.6) 0 (0.0)
Lombardia 88 (12.1) 50 (42.0) 3 (3.6) 2 (100) 9 (13.7) 20 (6.0) 4 (3.2)
AP Bolzano 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0) 0 (0.0) 1 (0.8)
AP Trento 4 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 2 (3.0) 2 (0.6) 0 (0.0)
Veneto 33 (4.5) 0 (0.0) 7 (8.5) 0 (0.0) 2 (3.0) 20 (6.0) 4 (3.1)
Friuli–VG 14 (1.9) 4 (3.4) 2 (2.4) 0 (0.0) 1 (1.6) 4 (1.2) 3 (2.4)
Liguria 31 (4.2) 11 (9.2) 6 (7.2) 0 (0.0) 0 (0) 4 (1.2) 10 (7.9)
Emilia-Romagna 57 (7.8) 14 (11.8) 22 (26.5) 0 (0.0) 12 (18.2) 4 (1.2) 5 (4.0)
Toscana 76 (10.4) 6 (5.0) 3 (3.6) 0 (0.0) 4 (6.1) 59 (17.7) 4 (3.2)
Marche 23 (3.2) 4 (3.4) 7 (8.5) 0 (0.0) 2 (3.0) 7 (2.1) 3 (2.4)
Lazio 162 (22.2) 0 (0.0) 8 (9.6) 0 (0.0) 8 (12.1) 128 (38.3) 18 (14.3)
Umbria 20 (2.7) 0 (0.0) 0 (0.0) 0 (0.0) 3 (4.5) 17 (5.1) 0 (0.0)
Abruzzo 26 (3.6) 13 (11.0) 2 (2.4) 0 (0.0) 0 (0.0) 4 (1.2) 7 (5.5)
Puglia 7 (1.0) 0 (0.0) 3 (3.6) 0 (0.0) 0 (0.0) 1 (0.3) 3 (2.4)
Basilicata 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.3) 0 (0.0)
Calabria 13 (1.8) 0 (0.0) 0 (0.0) 0 (0.0) 5 (7.6) 5 (1.5) 3 (2.4)
Campania 33 (4.5) 0 (0.0) 1 (1.2) 0 (0.0) 6 (9.1) 5 (1.5) 21 (16.7)
Sicilia 63 (8.6) 0 (0.0) 0 (0.0) 0 (0.0) 2 (3.0) 22 (6.6) 39 (30.9)
Sardegna 21 (2.9) 1 (0.8) 14 (16.9) 0 (0.0) 3 (4.5) 2 (0.6) 1 (0.8)
HCW gender 730 (100) 119 (100) 83 (100) 2 (100) 66 (100) 334 (100) 126 (100)
Male 264 (36.2) 33 (27.7) 23 (27.7) 1 (50.0) 23 (34.8) 122 (36.5) 62 (49.2)
Female 466 (63.8) 86 (72.3) 60 (72.3) 1 (50.0) 43 (65.2) 212 (63.5) 64 (50.8)
HCW age 730 (100) 119 (100) 83 (100) 2 (100) 66 (100) 334 (100) 126 (100)
18–39 years 522 (71.5) 90 (75.6) 56 (67.5) 2 (100) 47 (71.2) 241 (72.2) 86 (68.2)
> 39 years 208 (28.5) 29 (24.4) 27 (32.5) 0 (0.0) 19 (28.8) 93 (27.8) 40 (31.8)
HCW vaccination status 676 (100) 113 (100) 76 (100) 2 (100) 64 (100) 306 (100) 115 (100)
Unvaccinated 610 (90.2) 112 (99.1) 68 (89.5) 2 (100) 59 (92.2) 265 (86.6) 104 (90.4)
Vaccinated
One dose 48 (7.1) 1 (0.9) 8 (10.5) 0 (0.0) 4 (6.3) 27 (8.8) 8 (7.0)
Two doses 12 (1.8) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.5) 8 (2.6) 3 (2.6)
Unknown n. of doses 6 (0.9) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 6 (2.0) 0 (0.0)
Measles genotype 203 (100) 20 (100) 11 (100) 1 (100) 30 (100) 99 (100) 42 (100)
B2 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.4)
B3 134 (66.0) 0 (0.0) 9 (81.8) 1 (100) 21 (70.0) 68 (68.7) 35 (83.3)
D4 2 (1.0) 2 (10.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
D8 64 (31.5) 17 (85.0) 2 (18.2) 0 (0.0) 8 (26.7) 31 (31.3) 6 (14.3)
D9 1 (0.5) 1 (5.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
H1 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.3) 0 (0.0) 0 (0.0)
Setting of infection 213 (100) 18 (100) 30 (100) 1 (100) 22 (100) 88 (100) 54 (100)
Hospital
ED 19 (8.9) 4 (22.3) 3 (10.0) 0 (0.0) 0 (0.0) 4 (4.6) 8 (14.8)
Ward 179 (84.0) 12 (66.7) 25 (83.4) 1 (100) 21 (95.5) 80 (90.8) 40 (74.1)
Community
Family 12 (5.6) 1 (5.5) 1 (3.3) 0 (0.0) 1 (4.5) 4 (4.6) 5 (9.3)
School 1 (0.5) 1 (5.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Workplace 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.8)
Nomadic camp 1 (0.5) 0 (0.0) 1 (3.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Case classification 730 (100) 119 (100) 83 (100) 2 (100) 66 (100) 334 (100) 126 (100)
Confirmed 636 (87.1) 101 (84.9) 70 (84.3) 2 (100) 57 (86.4) 302 (90.4) 104 (82.5)
Probable 44 (6.0) 10 (8.4) 8 (9.7) 0 (0.0) 6 (9.1) 15 (4.5) 5 (4.0)
Possible 50 (6.9) 8 (6.7) 5 (6.0) 0 (0.0) 3 (4.5) 17 (5.1) 17 (13.5)
Case type 658 (100) 97 (100) 74 (100) 2 (100) 62 (100) 305 (100) 118 (100)
Sporadic 365 (55.5) 69 (71.1) 34 (46.0) 1 (50.0) 19 (30.6) 182 (59.7) 60 (50.8)
Outbreak-associated 293 (44.5) 28 (28.9) 40 (54.0) 1 (50.0) 43 (69.4) 123 (40.3) 58 (49.2)
Number of outbreaks 157 13 21 1 25 61 36
AP: Autonomous Province; VG: Venezia Giulia; ED: Emergency Department.
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The vast majority of infections were contracted in hospitals
in each year considered. Overall, 8.9% of cases became
infected in Emergency Departments and 84% in other
wards. A small percentage of HCWs (5.6%) were infected by
a relative. The remaining settings were responsible for only
a single case each.
Most cases were reported as confirmed (87.1%), while
probable or possible cases accounted for 6% and 6.9%, respec-
tively. In general, sporadic cases were more frequently
reported than outbreak-associated cases (55.5% vs 44.5%);
nevertheless, in 2014 and 2016 most HCW cases were
involved in measles epidemics and in 2015 and 2018 the two
proportions (sporadic vs outbreak-associated) were similar.
Lastly, the total number of outbreaks that involved HCWs
over the study period was 157, ranging from a minimum of
one in 2015 and a maximum of 61 in 2017.
Between 1st January and 15th May 2019, according to the
surveillance system, 54/775 (7.0%) of notified measles cases
among people of working age occurred in HCWs (data not
shown), mainly in Lombardia and Lazio (20 and 15, respec-
tively). Mostly, these HCWs were female (63%), aged between
18 and 39 years (81.5%), and unvaccinated (86%). More than
65% of the infections took place in hospitals. Twenty-seven
cases were sporadic and 17 were outbreak-associated.
Analysis of measles outbreaks involving HCWs
Systematic review of the literature
Study selection. After removal of duplicates, 132 records
resulted from the initial search (Figure 1). Screening by title
and abstract selected 96 articles eligible for full text analysis,
from which 84 records were excluded either because the
measles outbreak(s) did not involve HCW infection (n = 61)
or because the measles outbreak(s) did not occur in Italy
(n = 23). Seven records were added to the previous 12 from
the reference lists of relevant articles retrieved. Finally, a total of
19 records were included in this systematic review. Of the 19
articles included in this systematic review, six referred to multi-
ple outbreaks,32-37 while 13 described single outbreaks.38-50
Quality assessment. The ORION checklist was used to eval-
uate the quality of the 19 reports. Sixteen items of the ORION
statement were considered applicable.
Considering the articles dealing with one outbreak, the
majority of the items provided by the ORION statement
were followed by each study, with the exception of the setting
(adequately described in only 53.8% of the outbreaks) and the
outbreak-related costs (never analyzed).
Considering the articles dealing with multiple measles out-
breaks, the majority of the items provided by the ORION
statement were followed by each study, with the exception
of the control measures (reported in only three reports) and
the economic impact (never investigated).
Characteristics of measles outbreaks. The data in the reports
on multiple outbreaks were heterogeneous (Table 2). Two
articles referred to a single city (Bologna and Milano) and
another two referred to a particular Italian Region (Lazio and
Emilia-Romagna), while the final two reports covered
outbreaks that occurred throughout the country. The period
analyzed in the reports ranged from a minimum of four
months to a maximum of 15 months, and the size of the
outbreaks varied from 26 to 5568 cases. The proportion of
infected HCWs varied markedly between studies, with the
highest percentages reported by Emilia-Romagna in 2016
(20.8%) and Milano (Lombardia) in 2017 (4.9%). Regarding
virus genotype, B3 was the most represented, while D4 dis-
appeared after 2010–2011, and D8 began to circulate in
2009–2010.
Of the 13 articles describing single outbreaks, two referred
to the same outbreak, while one article reported two separate
outbreaks, giving a total of 13 single measles outbreaks
(Table 3). The Regions reporting the highest number of single
outbreaks were Puglia and Emilia Romagna (n = 3), followed
by Toscana (n = 2), while only one outbreak was described by
AP Bolzano, Lombardia, Marche, Sicilia and Sardegna. The
outbreaks occurred between 2006 and 2018, with 2017 being
the most represented year. The index case was identified in 12
outbreaks: ten (83.3%) derived from patients admitted to
hospital for measles-related symptoms who were not
promptly diagnosed and isolated, while in two outbreaks
(16.7%) the index cases were HCWs. All outbreaks (100%)
reached the hospital setting and in nine outbreaks (69.2%) the
community was also involved. The outbreak size was mostly
large, with eight outbreaks (61.5%) involving more than ten
people; two outbreaks (15.4%) were categorized as medium,
while the remaining three (23.1%) were small. The number of
infected HCWs was available in eleven cases; in three out-
breaks (27.3%) only one HCW was implicated, in one case
(9.1%) two HCWs were infected and in the other outbreaks
(63.6%) more than three HCWs were involved. When avail-
able, the proportion of HCWs infected out of the total num-
ber of cases ranged from 1/17 to 4/5. Regarding the genotype,
in 2006 only D4 was reported, whereas B3 was the most
frequently recorded after 2014.
Measles and rubella aggregate outbreak reporting forms.
From 2014 to 2018, 64 measles and rubella outbreak reporting
forms detailed epidemiological features of the outbreaks
involving HCWs. In particular, we found descriptions of
52.4% (11/21) of the outbreaks that occurred in 2014, 100%
(1/1) of the outbreaks in 2015, 52% (13/25) of the outbreaks
in 2016, 36.1% (22/61) of the outbreaks in 2017, and 47.2%
(17/36) of the outbreaks in 2018. The main characteristics of
such outbreaks are illustrated in Table 4.
Most outbreaks occurred in only one Region, apart from
one case that was reported as having spread across two
Regions in 2016. In general, the outbreaks were mainly noti-
fied by Toscana and Emilia-Romagna.
The index case was identified in 54 outbreaks: 19 outbreaks
(35.2%) originated from patients admitted to hospital for
measles-related symptoms, 18 index cases (33.3%) were
HCWs, twelve (22.2%) were hospitalized patients, four
(4.4%) were defined as hospital visitors (i.e. patients’ relatives,
outpatients) and in one case (1.8%) the infection started from
someone outside the hospital who had contact with the HCW.
Interestingly, the identification of patients admitted to hospi-
tal as the source of infection showed a gradual increase over
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the study period, whereas the reporting of HCWs as index
cases peaked in 2017. No further information on the role of
HCWs in amplifying the measles outbreaks was available.
Most outbreaks remained confined to people working in or
attending hospitals (46.9%) or occurred in both hospital and
community settings (36.0%), while only 11 outbreaks (17.2%)
occurred only in the community and in these cases, even if
HCWs were infected, the outbreaks did not spread to hospi-
tals. Overall, almost 80% of the outbreaks were of small size
and this category was nearly always the most predominant in
each individual year. By contrast, outbreaks of medium and
large size occurred only between 2016 and 2018. In general,
the number of infected HCWs was only one in 35 cases, while
24 outbreaks (37.5%) involved from two to three HCWs and,
lastly, five outbreaks (7.8%) included more than three HCWs.
Notably, while outbreaks with a low number of infected
HCWs occurred throughout the study period, outbreaks
with more than three HCWs were only reported in the last
years.
Discussion
HCWs are a trusted source of information on vaccine safety
and efficacy, and even though they should be highly
Figure 1. PRISMA flow diagram of the review process.
HUMAN VACCINES & IMMUNOTHERAPEUTICS 5
motivated to protect patients and society,20 low vaccination
coverages have led to a significant proportion of HCWs
becoming infected during the current epidemic peaks.20,51
Our study represents a systematic analysis of measles cases
among Italian HCWs.
According to the national surveillance system, approxi-
mately 7% of measles cases occurring in working-age peo-
ple still involve HCWs. Most of these are unvaccinated
subjects aged between 18 and 39, suggesting that vaccina-
tion coverage is still low in younger adults and, given their
consistent involvement in measles outbreaks, HCWs may
be critical for the elimination process. Overall, the rate of
laboratory investigations, with approximately 13% of HCW
measles cases not confirmed, was quite satisfactory.
Additionally, considering that the significant number of
cases classified as sporadic was probably due to ineffective
identification of the transmission chain and that the major-
ity of HCWs contracted the virus in a hospital setting, it
means that the percentage of measles cases linked to HCW
infection may rise significantly when we take into account
not only the HCWs, but also patients and hospital visitors.
It is well-known that the healthcare setting carries a high
risk of viral transmission52 and that vaccination is the only
reliable protection against nosocomial spread of measles;53
for these reasons, the adoption of more stringent HCW
vaccination policies at national level could represent a key
measure for directly protecting HCWs themselves, indir-
ectly protecting their patients and limiting the spread of
any outbreak.
Although the systematic review found 19 reports of good
quality, some methodological limitations should be outlined:
(i) a detailed description of the settings was lacking in almost
half of the single outbreak reports; (ii) the control measures
were omitted in some cases; (iii) the economic impact of the
outbreaks was not mentioned in any report.
In spite of the heterogeneous nature of the data, we wit-
nessed an increasing reporting of HCWs’ susceptibility to
measles. Only three Regions published articles that described
multiple measles outbreaks involving HCWs, half of them in
the last three years. Moreover, the highest proportions of
infected HCWs were reported in 2016 and 2017, which,
given the higher measles incidence rate of the last years,
could confirm the presence of an important vaccination gap
in this group.
Similar considerations could be applied to single measles
outbreaks, which were described by only few Regions. Since
patients seeking care at the Emergency Department were the
main source of infection, it is crucial for all HCWs to imme-
diately recognize the prodromal phase of the infection and
promptly isolate such individuals to avoid severe complica-
tions for susceptible patients.54,55 No less importantly, HCWs
may transmit measles to susceptible coworkers and family
members, as happened in the reported outbreaks. It is funda-
mental to remember that, when more than one HCW is
involved, the delivery of healthcare services may be compro-
mised and the institutions involved can suffer additional costs
due to the need for implementation of emergency measures.55
In particular, nosocomial outbreaks of measles are associated
Table 2. Characteristics of multiple measles outbreaks occurring in Italy and involving at least one healthcare worker (HCW) included in the systematic review.
Author, year of
publication Year (duration)
Geographical area (City, Region or
Region)
Number of infected HCWs/total number of confirmed
cases (%)
Measles
genotype
Calza, 2009 2007–2008
(6 months)
Bologna, Emilia-Romagna 1/26 (3.8) not reported
Amendola, 2017 2017 (4 months) Milano, Lombardia 10/203 (4.9) D8, B3
Curtale, 2010 2006–2007
(15 months)
Lazio 4/449 (0.9) D4, B3
Piccirilli, 2017 2016 (12 months) Emilia-Romagna 15/72 (20.8) B3, D8
Filia, 2011 2009–2010
(15 months)
15/21 Italian Regions and Autonomous
Provinces
34/2151 (1.6) D4, D8, B3
Filia, 2013 2010–2011
(15 months)
20/21 Italian Regions and Autonomous
Provinces
185/5568 (3.3) D4, D8, B3, D9,
H1, A
Table 3. Characteristics of single measles outbreaks occurring in Italy and involving at least one healthcare worker (HCW) included in the systematic review.
Author, year of
publication
Year (duration of the
outbreak)
Region or
Province
Index
case Setting
Number of infected HCWs/total number of
cases
Measles
genotype
Boncompagni, 2006
Bonanni, 2007
2006 (5 months) Toscana patient* H, C 8/40 D4
Filia, 2007 2006 (3 months) AP Bolzano patient* H, C 1/17 D4
Filia, 2008 2007 (n.s.) Emilia-Romagna patient* H 3/4 not reported
Tafuri, 2009 2008 (1 month) Puglia patient* H 1/2 not reported
Barbadoro, 2012 2011 (2 months) Marche patient* H 4/5 not reported
Filia, 2015 2014 (6 months) Sardegna patient* H 15/80 B3
Cozza, 2014 2014 (4 months) Puglia patient* H, C n.s./32 B3
Filia, 2016 2016 (4 months) Emilia-Romagna patient* H, C 7/17 B3.1
2016 (2 months) Emilia-Romagna HCW H, C 5/7 B3.1
Rovida, 2018 2017 (2 months) Lombardia patient* H, C n.s./16 H1
Palamara, 2017 2017 (7 months) Sicilia unknown H, C 2/57 B3
Porretta, 2017 2017 (3 months) Toscana HCW H, C 15/35 B3.1
Martinelli, 2018 2018 (2 months) Puglia patient* H, C 1/8 not reported
* Patient admitted to hospital.
H: Hospital; C: Community; AP: Autonomous Province; n.s.: not specified.
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with absenteeism of susceptible HCWs after exposure, disrup-
tion of healthcare services and significant costs resulting from
containment efforts.56 On these grounds, the education and
training of HCWs to allow them to promote and perform
missing vaccinations after pre-vaccination screening could
represent a cost-effective measure that would protect patients
and HCWs, and would minimize the economic impact.15,57
Regarding reporting of measles genotype, the results are
consistent with the trends described by the Measles and
Rubella National Reference Laboratory of the Italian NIH:
B3 and D8 co-circulated from 2014 to 2018, while D4 dis-
appeared after 2014.58,59
Despite some improvements in the measles and rubella
aggregate reporting forms,60 a non-uniform degree of com-
pleteness of reporting was observed. It may not be
a coincidence that the Regions that largely described the out-
breaks were Toscana and Emilia-Romagna, which are ranked
as well-performing Regions in the Measles Surveillance
System.60 The WHO states that measles surveillance data
should guide the decision-making process in disease elimina-
tion programs.61 Accurate investigations and subsequent
reporting are fundamental to an understanding of transmis-
sion patterns and for monitoring measles outbreaks, thereby
contributing to the identification of barriers and leading to
appropriate adjustment of immunization strategies. In this
context, our study suggests that outbreak reporting should
be further improved to enhance the definition of plans for
successful measles control.
To summarize, using multiple data sources highlighted
different key aspects of the impact of measles on Italian
HCWs. For example, most HCWs contracted the infection
in a hospital setting, and hospitals were also involved in the
majority of outbreaks. This is a crucial point to consider in
terms of either morbidity and mortality of the patients or the
economic impact on the institutions concerned. Second,
although some Regions were more affected than others, our
data show that HCW measles cases persist nationwide.
Therefore, it may now be time to circumvent the regional
fragmentation of the regulatory framework on vaccination
policies by acting at the national level.62 Last but not least,
given that the vast majority of HCWs were aged between 18
and 39, our data suggest that a consistent vaccination gap may
still exist in young adults.1
This study has some strengths and limitations. The main
strength is the comprehensive collection and analysis of the avail-
able evidence on measles infections among HCWs. To the best of
our knowledge, this is also the first attempt to both investigate
HCW measles cases and systematically describe the main char-
acteristics of the outbreaks in which they were involved. This
combination of aspects provides a comprehensive picture of the
phenomenon of HCWs’ susceptibility to measles in the last years.
We anticipate, therefore, that this study will attract the attention of
decision makers at both the national and international levels.
By contrast, the major limitations are represented by the
lack of accuracy of some data sources. Unfortunately, we are
aware that the Italian Regions may have only partially and
Table 4. Characteristics of measles outbreaks occurring in Italy and involving at least one healthcare worker (HCW) retrieved from the measles and rubella aggregate
outbreak reporting forms from 2014 to 2018.
Total 2014 2015 2016 2017 2018
N (%) N (%) N (%) N (%) N (%) N (%)
Region (65)* 65* (100) 11 (100) 1 (100) 14* (100) 22 (100) 17 (100)
Piemonte 1 (1.5) 0 (0.0) 0 (0.0) 1 (7.1) 0 (0.0) 0 (0.0)
Lombardia 6 (9.2) 0 (0.0) 1 (100) 0 (0.0) 0 (0.0) 5 (29.3)
AP Trento 1 (1.5) 0 (0.0) 0 (0.0) 1 (7.1) 0 (0.0) 0 (0.0)
Veneto 3 (4.6) 0 (0.0) 0 (0.0) 1 (7.1) 0 (0.0) 2 (11.8)
Friuli–Venezia Giulia 2 (3.1) 0 (0.0) 0 (0.0) 1 (7.1) 0 (0.0) 1 (5.9)
Liguria 1 (1.5) 1 (9.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Emilia-Romagna 17 (26.2) 7 (63.6) 0 (0.0) 4 (28.7) 3 (13.6) 3 (17.6)
Toscana 18 (27.7) 1 (9.1) 0 (0.0) 2 (14.3) 13 (59.1) 2 (11.8)
Lazio 5 (7.7) 1 (9.1) 0 (0.0) 3 (21.5) 0 (0.0) 1 (5.9)
Abruzzo 2 (3.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (11.8)
Puglia 2 (3.1) 1 (9.1) 0 (0.0) 0 (0.0) 0 (0.0) 1 (5.9)
Sicilia 4 (6.2) 0 (0.0) 0 (0.0) 0 (0.0) 4 (18.2) 0 (0.0)
Sardegna 3 (4.6) 0 (0.0) 0 (0.0) 1 (7.1) 2 (9.1) 0 (0.0)
Index case (54)** 54 (100) 6 (100) 1 (100) 11 (100) 20 (100) 16 (100)
Patient admitted to hospital 19 (35.2) 1 (16.7) 0 (0.0) 5 (45.5) 5 (25.0) 8 (50.0)
HCW 18 (33.3) 0 (0.0) 1 (100) 3 (27.3) 10 (50.0) 4 (25.0)
Hospitalized patient 12 (22.2) 5 (83.3) 0 (0.0) 2 (18.2) 2 (10.0) 3 (18.8)
Hospital visitor 4 (7.4) 0 (0.0) 0 (0.0) 0 (0.0) 3 (15.0) 1 (6.2)
People living in the community 1 (1.9) 0 (0.0) 0 (0.0) 1 (9.0) 0 (0.0) 0 (0.0)
Setting (64)** 64 (100) 11 (100) 1 (100) 13 (100) 22 (100) 17 (100)
Hospital-community 23 (35.9) 3 (27.3) 0 (0.0) 6 (46.1) 6 (27.3) 8 (47.0)
Hospital 30 (46.9) 7 (63.6) 1 (100) 5 (38.5) 10 (45.4) 7 (41.2)
Community 11 (17.2) 1 (9.1) 0 (0.0) 2 (15.4) 6 (27.3) 2 (11.8)
Outbreak size (64)** 64 (100) 11 (100) 1 (100) 13 (100) 22 (100) 17 (100)
Small 51 (79.7) 11 (100) 1 (100) 10 (76.9) 17 (77.3) 12 (70.6)
Medium 9 (14.1) 0 (0.0) 0 (0.0) 2 (15.4) 3 (13.6) 4 (23.5)
Large 4 (6.2) 0 (0.0) 0 (0.0) 1 (7.7) 2 (9.1) 1 (5.9)
Number of infected HCWs (64)** 64 (100) 11 (100) 1 (100) 13 (100) 22 (100) 17 (100)
1 35 (54.7) 4 (36.4) 1 (100) 6 (46.2) 14 (63.6) 10 (58.8)
2–3 24 (37.5) 7 (63.6) 0 (0.0) 6 (46.2) 5 (22.8) 6 (35.3)
>3 5 (7.8) 0 (0.0) 0 (0.0) 1 (7.6) 3 (13.6) 1 (5.9)
* Number of outbreaks considering that one outbreak was notified by two Regions.
** Number of outbreaks with data available.
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inconsistently recorded measles cases among HCWs in the
national surveillance system, probably resulting in under-
reporting. Nevertheless, this bias may have been constant
over the study period and, if it were corrected, it would only
reinforce the demand for improvements in HCW vaccina-
tion programs. Moreover, a proportion of the outbreaks
involving HCWs were not properly described in the measles
and rubella outbreak reporting forms, and therefore they
were impossible to synthesize. In particular, there is still
a huge disparity across the Italian Regions in the quality
of epidemiological reporting. Since this affected the avail-
ability of data, partly limiting the generalizability of the
epidemiological features we found, the strengthening of
the surveillance reporting system is essential for the mon-
itoring of measles eradication and for the characterization of
other localized populations with low vaccination coverage.
Conclusion
In spite of the remarkable progress made over the last two
years, our data are consistent in showing that the measles
elimination program in Italy is far from being completed
and transmission of the measles virus in healthcare settings
is still significant. Beyond serious morbidity and mortality,
nosocomial outbreaks of measles are costly and disrupt the
quality and safety of healthcare services. Since HCWs play
a critical role in nosocomial transmission, the implementation
of vaccination policies that aim to increase the HCWs’ immu-
nization rate is of the utmost importance in preventing the
infection of both HCWs and patients, in limiting the eco-
nomic impact of outbreaks on the institutions affected, and in
finally achieving measles elimination in Italy.
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